4 Largecap FII Holding Higher Than DII Holding Stocks to Watch for Future Multibagger Potential: ICICI Bank, Shriram Finance, Torrent Pharma and Laurus Labs
- October 30, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
ICICI Bank Rs 1,386.60. Shriram Finance Rs 841.10. Torrent Pharma Rs 4,580. Laurus Labs Rs 2,244. Market caps from Rs 1.18 lakh crore to Rs 9.53 lakh crore. Data as of 29 Oct 2026.
Quick Answer
ICICI Bank, Shriram Finance, Torrent Pharma and Laurus Labs are the 4 picks in this FII holding higher than DII holding stocks watchlist, with market caps between Rs 1.18 lakh crore and Rs 9.53 lakh crore. ICICI Bank stands out for the lowest PE of the group at 15.95, while Shriram Finance offers the fastest profit growth, 38.64% a year since FY22. PE ratios run from 15.95 to 108.57, so compare each one with its industry PE before investing. All figures are as of 29 October 2026.
FII holding higher than DII holding stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. ICICI Bank, Shriram Finance, Torrent Pharma and Laurus Labs meet that test, with market caps from Rs 1.18 lakh crore to Rs 9.53 lakh crore and ICICI Bank offering the lowest PE of the group at 15.95. Each of these companies has a foreign institutional holding at least 3 percentage points above the domestic institutional holding, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a foreign institutional holding at least 3 percentage points above the domestic institutional holding, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening FII holding higher than DII holding stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 29 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are FII Holding Higher Than DII Holding Stocks and Why Do They Attract Multibagger Interest?
FII holding higher than DII holding stocks are shares of large companies in which foreign funds own clearly more than domestic funds, a sign that global investors have picked these businesses as favourites. The four here cover private banking, vehicle finance, pharmaceuticals and pharmaceutical ingredients.
Foreign funds study companies across many countries, so a bigger foreign stake than a domestic stake shows that global money sees value in the business, and rising profit supports that view. For FII holding higher than DII holding stocks, both FY26 and the latest quarter showed growth. Whichever way you read FII holding higher than DII holding stocks, the common thread is rising profit backed by complete financial data. With FII holding higher than DII holding stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for FII holding higher than DII holding stocks are complete. Read each company’s latest results and exchange filings before acting on FII holding higher than DII holding stocks.
FII Holding Higher Than DII Holding Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 29 October 2026. ICICI Bank has the lowest PE of the group at 15.95, while Torrent Pharma posts the highest return on equity at 25.49%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| ICICI Bank | 1,386.60 | 9,53,334 | 15.95 | 12.05 | 15.00% | 2.55 | 1,187.60 to 1,480.00 |
| Shriram Finance | 841.10 | 2,08,485 | 18.42 | 17.68 | 15.21% | 1.98 | 662.25 to 1,153.70 |
| Torrent Pharmaceuticals | 4,580 | 1,73,856 | 80.64 | 36.42 | 25.49% | 20.67 | 3,480.60 to 5,250.00 |
| Laurus Labs | 2,244 | 1,18,375 | 108.57 | 36.42 | 16.77% | 22.33 | 864.70 to 2,244.00 |
ICICI Bank: 22.29% Profit CAGR Since FY22
ICICI Bank is one of the largest private sector banks in India, with a strong retail and digital franchise. It reported FY26 total income of Rs 3,12,118.36 crore, up 5.95% year on year, and net profit of Rs 57,673.39 crore, up 5.98%. Net profit has compounded at 22.29% a year since FY22, while total income has grown 18.64% a year.
In the June 2026 quarter, total income rose 6.86% to Rs 79,689.22 crore and net profit grew 12.62% to Rs 16,209.74 crore. The share price has gained 85.57% over five years. Foreign investors raised their holding from 45.56% in September 2025 to 50.44% in September 2026. The stock trades at a PE of 15.95 against an industry PE of 12.05, with a return on equity of 15.00%.
Shriram Finance: 38.64% Profit CAGR Since FY22
Shriram Finance is a major NBFC focused on commercial vehicle, small business and personal loans. It reported FY26 total income of Rs 48,192.65 crore, up 15.13% year on year, and net profit of Rs 10,004.20 crore, up 6.16%. Net profit has compounded at 38.64% a year since FY22, while total income has grown 25.75% a year.
The stock trades at a PE of 18.42 against an industry PE of 17.68, with a return on equity of 15.21%. In the June 2026 quarter, total income rose 16.26% to Rs 13,418.74 crore and net profit grew 59.95% to Rs 3,447.26 crore. The share price has gained 239.61% over five years and 40.91% over the past year. Domestic institutions raised their holding from 18.66% in September 2025 to 19.90% in June 2026.
Torrent Pharma: 28.79% Profit CAGR Since FY22
Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.
In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 194.63% over five years and 29.72% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026. The stock trades at a PE of 80.64 against an industry PE of 36.42, with a return on equity of 25.49%.
Laurus Labs: Revenue Up 22.01% in FY26
Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.
The stock trades at a PE of 108.57 against an industry PE of 36.42, with a return on equity of 16.77%. In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.40% over five years and 137.53% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026.
FII Holding Higher Than DII Holding Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these FII holding higher than DII holding stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Total Income (Rs Cr) | Net Profit (Rs Cr) | Income Growth (YoY) | 4-Year Income CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| ICICI Bank | 3,12,118.36 | 57,673.39 | 5.95% | 18.64% | 22.29% |
| Shriram Finance | 48,192.65 | 10,004.20 | 15.13% | 25.75% | 38.64% |
| Torrent Pharma | 13,886.15 | 2,138.18 | 20.34% | 12.38% | 28.79% |
| Laurus Labs | 6,867.85 | 889.85 | 22.01% | 8.53% | 1.68% |
Check the Univest Screener for live data on these FII holding higher than DII holding stocks
Institutional Holding in ICICI Bank, Shriram Finance, Torrent Pharma and Laurus Labs
Institutional holding shows who is backing these FII holding higher than DII holding stocks alongside the promoter. The table uses the latest reported quarter for each. ICICI Bank has the deepest institutional backing, with FII and DII together holding 92.22% as of September 2026. Domestic institutions increased their holding over the past year in Shriram Finance (from 18.66% to 19.90%), Torrent Pharma (from 9.28% to 12.87%) and Laurus Labs (from 11.94% to 13.74%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| ICICI Bank | Nil | 50.44% | 41.78% | 7.78% | September 2026 |
| Shriram Finance | 20.30% | 54.77% | 19.90% | 5.04% | June 2026 |
| Torrent Pharma | 60.78% | 17.97% | 12.87% | 8.38% | July 2026 |
| Laurus Labs | 27.47% | 28.00% | 13.74% | 30.78% | June 2026 |
Risks to Weigh in FII Holding Higher Than DII Holding Stocks
Being careful with FII holding higher than DII holding stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Laurus Labs trades at a PE of 108.57 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between FII Holding Higher Than DII Holding Stocks
Picking from FII holding higher than DII holding stocks comes down to four checks, applied in order.
- Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
- Compare each PE with the industry PE (12.05 to 36.42) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track ICICI Bank, Shriram Finance, Torrent Pharma and Laurus Labs live prices.
Conclusion
Among FII holding higher than DII holding stocks, ICICI Bank stands out for the lowest PE of the group at 15.95, Shriram Finance for the fastest profit growth, 38.64% a year since FY22, Torrent Pharma for the highest return on equity at 25.49% and Laurus Labs for the strongest latest-quarter profit growth at 124.73%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing FII holding higher than DII holding stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on FII Holding Higher Than DII Holding Stocks to Watch
Which are the best FII holding higher than DII holding stocks to watch for multibagger potential?
Ans. ICICI Bank, Shriram Finance, Torrent Pharma and Laurus Labs are the 4 names this list highlights, with market caps of Rs 9,53,334 crore, Rs 2,08,485 crore, Rs 1,73,856 crore and Rs 1,18,375 crore respectively. ICICI Bank is notable for the lowest PE of the group at 15.95. Shriram Finance stands out for the fastest profit growth, 38.64% a year since FY22. Torrent Pharma offers the highest return on equity at 25.49%. Laurus Labs brings the strongest latest-quarter profit growth at 124.73%. These are watchlist names for FII holding higher than DII holding stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Torrent Pharma a good stock for long-term investors?
Ans. Torrent Pharma has a return on equity of 25.49%, a PE of 80.64 against an industry PE of 36.42 and a market cap of Rs 1,73,856 crore. Net profit has compounded at 28.79% a year since FY22, and FY26 revenue rose 20.34% while June 2026 quarter net profit grew 3.28%. Long-term returns in FII holding higher than DII holding stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Shriram Finance become a multibagger from here?
Ans. Shriram Finance has already gained 239.61% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in FII holding higher than DII holding stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.64% a year since FY22, and FY26 revenue rose 15.13%. At a PE of 18.42 against an industry PE of 17.68, valuation should be checked against that growth before investing.
What is the market cap of ICICI Bank, Shriram Finance, Torrent Pharma and Laurus Labs?
Ans. As of 29 October 2026, ICICI Bank has a market cap of Rs 9,53,334 crore, Shriram Finance has a market cap of Rs 2,08,485 crore, Torrent Pharma has a market cap of Rs 1,73,856 crore and Laurus Labs has a market cap of Rs 1,18,375 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on FII holding higher than DII holding stocks.
What are the risks of investing in FII holding higher than DII holding stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 108.57 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Laurus Labs trading at a PE of 108.57?
Ans. Laurus Labs’ PE of 108.57 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in FII holding higher than DII holding stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in ICICI Bank, Shriram Finance, Torrent Pharma and Laurus Labs?
Ans. As of the latest reported quarter, FII and DII together hold 92.22% of ICICI Bank (50.44% and 41.78%), 74.67% of Shriram Finance (54.77% and 19.90%), 30.84% of Torrent Pharma (17.97% and 12.87%) and 41.74% of Laurus Labs (28.00% and 13.74%). Rising institutional holding is a useful signal in FII holding higher than DII holding stocks, though it should be read with earnings trends rather than on its own.
